Key facts
- This page summarizes Cindy Reiss-Clark's Form 4 filing for WEST PHARMACEUTICAL SERVICES INC (WST).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 Feb 2025, 21:16.
Cindy Reiss-Clark - 18 Feb 2025 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- WST
- Reported as of
- 18 Feb 2025
- Net transaction value
- +$34,389
- SEC form
- 4
- Accepted by SEC
- 20 Feb 2025, 21:16:49 UTC
- Prior SEC filing
- 22 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Louis Lalli, as an agent for Cindy Reiss-Clark
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Cindy Reiss-Clark filed Form 4 for WEST PHARMACEUTICAL SERVICES INC (WST) on 20 Feb 2025.
Change
- Previous filing in this sequence was filed on 22 Feb 2024.
- Current net transaction value: +$34,389.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
WST
transaction
Common Stock
Options Exercise
- Transaction value
- $51,940
- Shares
- +246
- Change %
- +5%
- Price
- $211.00
- Shares after
- 5,131
- Date
- 18 Feb 2025
- Ownership
- Direct
WST
transaction
Common Stock
Tax liability
- Transaction value
- $17,551
- Shares
- -83
- Change %
- -1.6%
- Price
- $211.00
- Shares after
- 5,047
- Date
- 18 Feb 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
WST
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +1,162
- Change %
- Price
- $0.000000
- Shares after
- 1,162
- Date
- 18 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,162
- Exercise price
- $211.00
- Footnotes
- F1
WST
transaction
Derivative
Rst. Stock Unit
Award
- Transaction value
- $0
- Shares
- +503
- Change %
- Price
- $0.000000
- Shares after
- 503
- Date
- 18 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 503
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This award vests in four equal installments beginning on February 18, 2026.